Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cytocom Inc.

Start price
Target price
Perf. (%)
€2.60
11.03.20
-
16.03.20
-24.62%
16.03.20

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€2.28
11.03.20
-
12.03.20
22.81%
12.03.20

buy
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€78.50
11.03.20
-
16.03.20
-28.66%
16.03.20

Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.30
11.03.20
€2.45
16.03.20
-24.78%
16.03.20

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€12.40
11.03.20
€18.00
04.11.21
-7.21%
05.11.21

Could be worthwhile Investment >10% per year
buy
Therapix Biosciences Ltd ADR

Start price
Target price
Perf. (%)
€26.74
11.03.20
€70.00
20.07.20
-36.13%
20.07.20

buy
Theravance Biopharma

Start price
Target price
Perf. (%)
€22.20
11.03.20
€25.00
21.08.20
-29.73%
21.08.20

buy
ReproCell Inc

Start price
Target price
Perf. (%)
€2.12
11.03.20
-
04.11.21
-18.87%
05.11.21

buy
ReNeuron Group plc

Start price
Target price
Perf. (%)
€1.18
11.03.20
-
04.11.21
1.69%
05.11.21

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.45
11.03.20
€55.00
11.03.20
0.51%
11.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€352.50
10.03.20
€415.00
11.03.20
0.71%
11.03.20

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€12.98
10.03.20
€15.00
04.11.21
-9.41%
05.11.21

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€121.12
10.03.20
€130.00
20.03.20
-4.23%
20.03.20

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€413.60
10.03.20
-
16.03.20
-4.06%
16.03.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Inovio Pharma

Start price
Target price
Perf. (%)
€8.55
10.03.20
€3.00
10.03.20
-18.71%
10.03.20

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€3.26
10.03.20
€4.50
10.03.20
-17.73%
10.03.20

buy
Akorn Inc.

Start price
Target price
Perf. (%)
€0.72
10.03.20
€1.00
23.03.20
-37.51%
23.03.20

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€10.50
10.03.20
€17.00
10.03.20
4.08%
10.03.20

buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€19.00
10.03.20
-
10.05.20
8.42%
10.05.20

buy
Bayer AG

Start price
Target price
Perf. (%)
€58.93
10.03.20
€66.00
04.11.21
-18.79%
12.11.20

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€352.50
10.03.20
€400.00
02.04.20
17.02%
02.04.20

buy
Bayer AG

Start price
Target price
Perf. (%)
€60.29
10.03.20
-
11.03.20
-5.24%
11.03.20

buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€5.00
09.03.20
-
18.03.20
-17.71%
18.03.20

buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.42
09.03.20
€1.00
16.03.20
-27.42%
16.03.20

buy
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€15.27
09.03.20
-
06.04.20
-46.57%
06.04.20

Could be worthwhile Investment >10% per year
Good culture
Little innovation